Guess the Stock E43｜The growing stars of the Biotech Industry
Event Description:
This event is to help mooers learn more about the differences among companies and industries, identify hidden opportunities, and better navigate the market.
"Interest rate is like the gravity of the investment. Price is what you pay and value is what you get. Be fearful when others are greedy and be greedy when others are fearful." — Warren Buffett
Challenge Start >>
Rewards
4,000 points: All mooers who answer the following questions correctly and post thoughts of any length on any companies below will be considered winners. All winners will get an equal share of 4,000 points. (e.g., If 100 mooers win, each mooer will get 40 points.)
Cash Coupons: 3 users who give the best-quality comments will get USD 2 / SGD 2.8 cash coupons. (You can share investment ideas, trading experiences, and exploration of why Market Cap deviates among the companies.)
Questions
What companies do Company A, Company B, and Company C refer to, respectively?
What's the ranking of Companies A, B and C in terms of Market Capitalization?
Reference answer form: A>B>C or A<B<C or C<A≈B (within 10% deviation)
Tips: You can refer to the financial indicators' information below.
Company A: Phase 1 Study in EOAD – Interim Results
Source: The company's Q1 2023 Earnings Report
The company focused on discovering, developing, and commercializing RNA interference (RNAi) therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list.
Company B: The company's current pipelines
Source: The company's corporate presentation in January 2023
The company is engaged in discovering and developing novel cell therapies for oncological and other indications. With a team of more than 650 employees in the US, China, and Europe. The company has partnered strategically with Janssen Biotech to develop and commercialize an investigational BCMA-targeted CAR-T cell therapy.
Company C: Leading pharmaceutical products by sales worldwide in 2022
Source: Statista, 2023
The company is headquartered in New York and was founded in 1988. It originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its name. The company then branched out into the study of both cytokine and tyrosine kinase receptors.
More Hint:
● Company A: The blue line; Company B: The yellow line; Company C: The purple line
● Finding path: moomoo App → Markets→ Explore→ Stock Compare
How to Participate?
Add the stock tickers (e.g., $Tesla(TSLA.US)$), plus the Market Cap comparison and any comments on the above companies to your answers. Further investment ideas are also welcome.
Event Period: May 12 – May 19
This presentation is for information and educational use only and is not a recommendation or endorsement of any particular investment or investment strategy. See this link for more information.
Disclaimer: Moomoo Technologies Inc. is providing this content for information and educational use only.
Read more
Comment
Sign in to post a comment
Moomoo Community Official Account
Trade like a pro.
41KFollowers
81Following
31KVisitors
Follow
romancer : Company A: $Alnylam Pharmaceuticals (ALNY.US)$
Company B: $Legend Biotech (LEGN.US)$
Company C: $Regeneron Pharmaceuticals (REGN.US)$
Market Capitalization comparison:
Company B < Company A < Company C
Baby無齒 : Company A: $Alnylam Pharmaceuticals (ALNY.US)$
Company B: $Legend Biotech (LEGN.US)$
Company C: $Regeneron Pharmaceuticals (REGN.US)$
Market Capitalization comparison:
Company B < Company A < Company C
费北敬 : Company A: $Alnylam Pharmaceuticals (ALNY.US)$
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
Company B: $Legend Biotech (LEGN.US)$
Company C: $Regeneron Pharmaceuticals (REGN.US)$
Market Capitalization comparison:
Company B < Company A < Company C
All the above 3 company are under Pharma
mr_cashcow : Company A: $Alnylam Pharmaceuticals (ALNY.US)$
Company B: $Legend Biotech (LEGN.US)$
Company C: $Regeneron Pharmaceuticals (REGN.US)$
Market Capitalization comparison:
Company B < Company A < Company C
Alnylam has led the translation of RNA interference (RNAi) from Nobel Prize-winning discovery into an entirely new class of medicines, which we believe has the potential to help people all over the world to live longer, healthier, and fuller lives. Through pioneering science, unwavering commitment to patients, and our approved therapies and deep pipeline of investigational RNAi therapeutics, we have cemented our reputation for innovation and leadership in RNAi.
Legend Biotech is a global biotechnology company developing, manufacturing and commercializing life-saving therapies. Headquartered in Somerset, New Jersey, the company is developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy.
Regeneron is a leading science and technology company that delivers life-transforming medicines for serious diseases. Founded by physician-scientists more than 30 years ago, our science-driven approach has resulted in nine FDA-approved medicines and numerous product candidates in a range of diseases, including blindness-causing eye diseases, severe inflammatory conditions like asthma and atopic dermatitis, hematologic conditions, pain and infectious diseases such as Ebola and COVID-19
sociable Dingo_8604 : A: $Alnylam Pharmaceuticals (ALNY.US)$
B: $Legend Biotech (LEGN.US)$
C: $Regeneron Pharmaceuticals (REGN.US)$
B < A < C
$Legend Biotech (LEGN.US)$ is a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications. Their team of over 700 employees across the United States, China and Europe, along with differentiated technology, global development, and manufacturing strategies and expertise, provide them with the strong potential to discover, develop, and manufacture best-in-class cell therapies for patients in need.
Davidtkw : Company A: $Alnylam Pharmaceuticals (ALNY.US)$
Company B: $Legend Biotech (LEGN.US)$
Company C: $Regeneron Pharmaceuticals (REGN.US)$
Market Capitalization comparison:
Company B < Company A < Company C
Vegetable Oil : Company A: $Alnylam Pharmaceuticals (ALNY.US)$
Company B: $Legend Biotech (LEGN.US)$
Company C: $Regeneron Pharmaceuticals (REGN.US)$
Market capitalization comparison:
Company B < Company A < Company C
102126117 : Company A: $Alnylam Pharmaceuticals (ALNY.US)$
Company B: $Legend Biotech (LEGN.US)$
Company C: $Regeneron Pharmaceuticals (REGN.US)$
Market Capitalization comparison:
Company B < Company A < Company C
102237998 yh : Company A: $Ariram Pharmaceuticals (ALNY.US) $
Company B: $Legendary Creature (LEGN.US) $
C Company: $Regenerative Pharmaceuticals (REGN.US) $
Market capitalization comparison:
Company B < Company A < Company C
71791580 : Company A: $Alnylam Pharmaceuticals (ALNY.US)$
Company B: $Legend Biotech (LEGN.US)$
Company C: $Regeneron Pharmaceuticals (REGN.US)$
Market capitalization comparison:
Company B < Company A < Company C
View more comments...